9 completed, 4 unknown. 13 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Completed 9, Unknown 4 |
| Phase 2 | 3 | Unknown 2, Completed 1 |
Follow Cardiac Output, Low: new trials by email Literature Review of Cardiac Output, Low trials Research Report on Cardiac Output, Low
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exogenous Ketones for Acutely Decompensated HEart Failure 25g Ketone monoester without added salts, Placebo - Acute Heart Failure, Low Cardiac Output Syndrome | Phase 3 | Unknown | Institute for Clinical and Experimental Medicine | 24 | 2020-12-02 | 2021-01-06 |
| Spanish Randomized Clinical Trial to Compare Levosimendan Versus Placebo in Postoperative Cardiac Surgery (SPARTANS) Levosimendan, Placebos - Cardiac Output, Low | Phase 2 / Phase 3 | Unknown | María de los Ángeles Tena Pajuelo | 300 | 2020-06-17 | 2020-07-24 |
| Prophylactic Use of Milrinone After Congenital Heart Surgery in Infants Milrinone, Normal saline - Low Cardiac Output Syndrome, Cardiac Surgical Procedures | Phase 3 | Unknown | Shanghai Children's Medical Center | 520 | 2019-02-01 | 2019-01-30 |
| Nitric Oxide During Bypass for Arterial Switch Operation Nitric Oxide - Low Cardiac Output Syndrome, Transposition of Great Vessels | Phase 3 | Completed | Murdoch Childrens Research Institute | 300 | 2018-07-11 | 2024-04-18 |
| Liberal Versus Restrictive Use of Dobutamine in Cardiac Surgery Liberal dobutamine protocol, Restrictive dobutamine protocol - Cardiac Output, Low, Coronary Disease | Phase 3 | Completed | University of Sao Paulo | 160 | 2015-02-01 | 2022-03-16 |
| Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass Levosimendan, Placebo - Coronary Artery Bypass Grafting, Mitral Valve Surgery | Phase 3 | Completed | Tenax Therapeutics, Inc. | 882 | 2014-07-01 | 2018-06-21 |
| Preoperative Levosimendan in CABG Patients With Poor LV Function levosimendan, Placebo - Coronary Artery Bypass Grafting, Left Ventricular Dysfonction | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 335 | 2013-06-01 | 2016-02-25 |
| Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients Remote ischemic preconditioning stimulus, control - Death, Stroke | Phase 3 | Completed | Queen's University | 429 | 2012-02-01 | 2016-02-05 |
| Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy Perhexiline, Placebo marked PEXSIG - Myocardial Reperfusion Injury, Cardiac Output, Low | Phase 2 / Phase 3 | Unknown | University Hospital Birmingham | 220 | 2009-10-01 | 2011-08-11 |
| Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery Perhexiline, Placebo marked PEXSIG - Myocardial Reperfusion Injury, Cardiac Output, Low | Phase 2 / Phase 3 | Completed | University Hospital Birmingham | 290 | 2007-02-01 | 2010-05-20 |
| The Efficacy of Hypertonic Lactate Solution in CABG(Coronary Artery Bypass Grafting) Patients Hypertonic lactate, Ringer's lactate - Low Cardiac Output | Phase 3 | Completed | Innogene Kalbiotech Pte. Ltd | 66 | 2005-07-01 | 2007-09-14 |
| The Effects of Adrenaline and Milrinone in Patients With Myocardial Dysfunction After CABG adrenaline, milrinone - Cardiac Output, Low | Phase 3 | Completed | University of Luebeck | 60 | 2003-06-01 | 2015-06-03 |
| Efficacy, Safety of Hypertonic Lactate Soln. as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG Pats Hypertonic lactate, Ringer's lactate - Low Cardiac Output | Phase 3 | Completed | Innogene Kalbiotech Pte. Ltd | 230 | 2002-03-01 | 2007-09-14 |
Myocardial Reperfusion Injury (2) · Renal Insufficiency (2) · Aortic Valve Stenosis (1) · Coronary Disease (1) · Death (1) · Heart Defects, Congenital (1) · Hypertrophy, Left Ventricular (1) · Ketosis (1) · Myocardial Infarction (1) · Stroke (1) · Transposition of Great Vessels (1) · Ventricular Dysfunction, Left (1)
Cardiovascular Diseases (13) · Heart Diseases (13) · Pathological Conditions, Signs and Symptoms (13) · Signs and Symptoms (13) · Myocardial Ischemia (4) · Vascular Diseases (4) · Pathologic Processes (3) · Cardiomyopathies (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Postoperative Complications (2) · Reperfusion Injury (2) · Urogenital Diseases (2)
Simendan (3) · Milrinone (2) · Perhexiline (2) · Ringer's Lactate (2) · Epinephrine (1) · Nitric Oxide (1) · Riboflavin (1) · Saline Solution (1)
Innogene Kalbiotech Pte. Ltd (2) · University Hospital Birmingham (2) · Assistance Publique - Hôpitaux de Paris (1) · Institute for Clinical and Experimental Medicine (1) · María de los Ángeles Tena Pajuelo (1) · Murdoch Childrens Research Institute (1) · Queen's University (1) · Shanghai Children's Medical Center (1) · Tenax Therapeutics, Inc. (1) · University of Luebeck (1) · University of Sao Paulo (1)
Canada (3) · Indonesia (3) · United Kingdom (2) · Australia (1) · Brazil (1) · China (1) · Czechia (1) · France (1) · Malaysia (1) · Spain (1) · United States (1)
Domeinco Pagano, MD FRCS (2) · Xavier Leverve, MD, PhD (2) · Bernard Cholley, MD, PhD (1) · Darrin Payne, MD (1) · Elisabet B Berastegui Garcia, Cardiac surgery (1) · Gemma S Sanchez Espin, Cardiac Surgery (1) · Huiwen Chen, MD, PhD (1) · Iqbal Mustafa, MD (1) · John Alexander, MD (1) · Juan B Bustamante Munguira, Cardiac surgery (1) · Marc V Vives Santacana, anesthesiology (1)
PMID 17470271, PMID 19700350, PMID 23228403, PMID 23620700, PMID 24126568, PMID 24948413, PMID 25734940, PMID 25989324, PMID 27496105, PMID 27686343, PMID 27914501, PMID 28316276, PMID 28787507, PMID 29718383, PMID 33496877, PMID 35263653
2019 (1)